Combined 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and 123I-Iodometomidate (123I-IMTO) Imaging for Adrenal Neoplasia (FAMIAN Study) is a large multi-centre clinical trial funded by the Dutch Research Foundation as part of the ENSAT-CANCER platform that focuses on a large targeted imaging study. The PRESS team are responsible for all of the IT systems associated with the clinical study including the electronic Case Report Forms (eCRFs), the patient databases, the sample management and the underpinning security systems.

Melbourne Genomics Health Alliance (MGHA) is a large grant ($25m) funded by the Victorian Government. MGHA brings together the clinical, research and teaching strengths among Victoria’s leading hospitals and research organisations, with a vision to deliver genomic medicine into everyday healthcare.